IRONWOOD PHARMACEUTICALS, INC. Convertible Debt, Noncurrent
IRONWOOD PHARMACEUTICALS, INC. (IRWD) had Convertible Debt, Noncurrent of $199.16 million as of 2025-03-31, per its 10-Q filed 2025-05-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt, Excluding Current Maturities
us-gaap:ConvertibleDebtNoncurrent · last filed 2026-02-26
- 2025-03-31: Convertible Debt, Noncurrent $199.16M.
- 2024-12-31: Convertible Debt, Noncurrent $198.99M.
- 2024-09-30: Convertible Debt, Noncurrent $198.82M.
- 2024-06-30: Convertible Debt, Noncurrent $198.65M.
| Period end | Convertible Debt, Noncurrent |
|---|---|
| 2025-03-31 | $199.16M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $198.99M 10-K · filed 2026-02-26 |
| 2024-09-30 | $198.82M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $198.65M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $198.48M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $198.31M 10-K · filed 2025-03-31 |
| 2023-09-30 | $198.14M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $197.97M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $396.65M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $396.25M 10-K · filed 2024-02-16 |
| 2022-09-30 | $395.85M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $395.45M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $395.05M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $337.33M 10-K · filed 2025-03-31 |
| 2021-09-30 | $333.21M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $329.15M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $436.08M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $430.26M 10-K · filed 2022-02-18 |
| 2020-09-30 | $424.54M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $418.92M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $413.41M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $407.99M 10-K · filed 2021-02-17 |
| 2019-09-30 | $402.68M 10-Q · filed 2019-10-31 |
| 2019-06-30 | $274.39M 10-Q · filed 2019-07-30 |
| 2019-03-31 | $269.95M 10-Q · filed 2019-05-02 |
| 2018-12-31 | $265.60M 10-K · filed 2020-02-13 |
| 2018-09-30 | $261.36M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $257.21M 10-Q · filed 2018-08-06 |
| 2018-03-31 | $253.15M 10-Q · filed 2018-05-04 |
| 2017-12-31 | $249.19M 10-K · filed 2019-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |